GSA CAPITAL PARTNERS LLP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$402
-74.6%
126,812
-49.6%
0.03%
-82.7%
Q4 2022$1,581
-99.5%
251,384
+689.4%
0.20%
+326.1%
Q3 2022$344,000
-74.6%
31,846
-78.6%
0.05%
-74.7%
Q1 2022$1,356,000
-20.8%
148,804
+29.6%
0.18%
-15.3%
Q4 2021$1,713,000
+370.6%
114,815
+723.0%
0.22%
+424.4%
Q2 2021$364,000
+27.7%
13,951
+23.8%
0.04%
-12.8%
Q4 2020$285,000
+3.3%
11,273
+6.1%
0.05%
+46.9%
Q4 2019$276,00010,6220.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders